Brachial-radial Pressure Gradient Phenomenon in Critically Ill Patients Treated With Vasoactive Agents
Launched by JAGIELLONIAN UNIVERSITY · Jul 2, 2025
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how blood pressure readings may differ between two arteries in the arm (the brachial artery near the upper arm and the radial artery near the wrist) in very sick patients who are being treated with medicines called vasoactive agents. These medicines help support blood pressure and circulation in people experiencing shock or circulatory failure. The researchers want to find out how often there is a difference in pressure readings between these two arteries, whether this difference is bigger when higher doses of these medicines are used, and if the difference is linked to poorer blood flow to the body’s tissues.
Adults over 18 who are in the intensive care unit (ICU), have already received initial treatment for their condition, and are receiving continuous blood pressure monitoring through a small tube placed in their wrist artery may be eligible to take part. Participants will be observed while on vasoactive medicines, and measurements will be taken to compare blood pressure between the two arteries. The study does not involve additional treatments or interventions beyond these measurements. People who are pregnant, require certain types of heart support machines, or cannot have the blood pressure cuff properly placed on their arm will not be able to join. This study aims to help doctors better understand blood pressure monitoring in critically ill patients to improve care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adult (\>18 years) patients admitted to the ICU
- • must be after initial resuscitation
- • invasive blood pressure monitoring in the radial artery
- • need for vasoactive drug therapy
- Exclusion Criteria:
- • pregnancy
- • pressure transduction across invasive blood pressure circuit deemed to be inadequate
- • mechanical circulatory support
- • inability to match non-invasive cuff size to the patient's arm
- • need for any hemodynamic intervention during performing study's measurements
- • patient's decline to have the measurements done
About Jagiellonian University
Jagiellonian University, one of the oldest and most prestigious institutions of higher education in Poland, is a leading sponsor of clinical trials dedicated to advancing medical research and healthcare innovation. With a strong commitment to scientific excellence, the university leverages its extensive resources, multidisciplinary expertise, and collaborative network to conduct rigorous clinical studies that contribute to the development of new therapies and treatment strategies. Jagiellonian University emphasizes ethical research practices and strives to enhance patient outcomes through evidence-based findings, making significant contributions to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kraków, , Poland
Opole, , Poland
Warszawa, , Poland
Patients applied
Trial Officials
Zbigniew Putowski, MD PhD
Study Chair
Center for Intensive Care and Perioperative Medicine, Jagiellonian University Medical College, Cracow, Poland
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported